Patients with invasive breast cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Breast Cell Line, Tumor Axilla Lymph Nodes Tumor Cells, Cultured Mammary Glands, Human MCF-7 Cells Nipples Epithelial Cells Neoplastic Stem Cells

Organisms2

Mice, Nude Mice, SCID

Diseases39

Breast Neoplasms Carcinoma, Ductal, Breast Neoplasm Invasiveness Carcinoma, Intraductal, Noninfiltrating Carcinoma, Lobular Carcinoma in Situ Lymphatic Metastasis Breast Diseases Neoplasm Metastasis Neoplasm Recurrence, Local Breast Neoplasms, Male Carcinoma, Ductal Carcinoma Disease Progression Genetic Predisposition to Disease Neoplasms, Ductal, Lobular, and Medullary Neoplasms, Hormone-Dependent Fibrocystic Breast Disease Neoplasms, Second Primary Mammary Neoplasms, Experimental Ovarian Neoplasms Neoplasms, Basal Cell Adenocarcinoma, Mucinous Lung Neoplasms Cell Transformation, Neoplastic Neoplasms Prostatic Neoplasms Neovascularization, Pathologic Hyperplasia Fibroadenoma Adenocarcinoma Bone Neoplasms Colonic Neoplasms Osteoporosis, Postmenopausal Precancerous Conditions Stomach Neoplasms Triple Negative Breast Neoplasms Inflammatory Breast Neoplasms Pancreatic Neoplasms

Chemicals and Drugs54

Receptors, Estrogen Receptors, Progesterone Receptor, erbB-2 Tumor Markers, Biological Tamoxifen Raloxifene Antineoplastic Agents, Hormonal Selective Estrogen Receptor Modulators Neoplasm Proteins Ki-67 Antigen Antineoplastic Agents Estrogen Receptor Modulators Estrogen Receptor alpha Estrogens Keratin-6 BRCA2 Protein BRCA1 Protein RNA, Messenger Keratin-5 Aromatase Inhibitors DNA, Neoplasm Progestins Receptor, Epidermal Growth Factor Tumor Suppressor Protein p53 Dydrogesterone Antibodies, Monoclonal, Humanized Cadherins Antigens, Neoplasm Antibodies, Monoclonal Estrogen Antagonists Anticarcinogenic Agents RNA, Small Interfering Tumor Suppressor Proteins Transcription Factors Estradiol Cyclophosphamide Fluorouracil Cyclin D1 Keratins Bone Density Conservation Agents Epirubicin RNA, Neoplasm Contraceptives, Oral Nitriles Nuclear Proteins Carbonic Anhydrases Urokinase-Type Plasminogen Activator Paclitaxel Cancer Vaccines DNA Primers Proto-Oncogene Proteins c-bcl-2 DNA-Binding Proteins Antigens, CD24 Triazoles

Analytical, Diagnostic and Therapeutic Techniques and Equipment84

Mammography Prognosis Mastectomy Neoplasm Staging Immunohistochemistry Mastectomy, Segmental Risk Factors Case-Control Studies Survival Analysis Incidence Tissue Array Analysis Disease-Free Survival Early Detection of Cancer Follow-Up Studies Risk Assessment Risk Cohort Studies Multivariate Analysis Neoplasm Grading Chemotherapy, Adjuvant SEER Program Proportional Hazards Models Retrospective Studies Survival Rate Prospective Studies Odds Ratio Registries Estrogen Replacement Therapy Gene Expression Profiling Mass Screening Treatment Outcome Predictive Value of Tests Sentinel Lymph Node Biopsy Hormone Replacement Therapy Kaplan-Meier Estimate Ultrasonography, Mammary Reverse Transcriptase Polymerase Chain Reaction Antineoplastic Combined Chemotherapy Protocols Radiotherapy, Adjuvant Logistic Models In Situ Hybridization, Fluorescence Sensitivity and Specificity Lymph Node Excision Combined Modality Therapy Tumor Burden Mammaplasty Biopsy, Needle Immunoenzyme Techniques Reproducibility of Results Mammary Neoplasms, Experimental Confidence Intervals Breast Self-Examination Questionnaires Oligonucleotide Array Sequence Analysis Neoadjuvant Therapy Blotting, Western Mastectomy, Radical Mastectomy, Modified Radical Reproductive History Biopsy, Large-Core Needle Polymerase Chain Reaction Biopsy Mitotic Index Radiotherapy Neoplasm Transplantation Xenograft Model Antitumor Assays Transfection False Negative Reactions Chi-Square Distribution Transplantation, Heterologous Palpation Randomized Controlled Trials as Topic Pilot Projects Models, Statistical Probability Breast Implants In Situ Hybridization Cluster Analysis ROC Curve Regression Analysis Patient Selection Clinical Trials as Topic Analysis of Variance Body Mass Index

Psychiatry and Psychology3

Breast Feeding Breast Self-Examination Alcohol Drinking

Phenomena and Processes50

Postmenopause Gene Expression Regulation, Neoplastic Premenopause Genes, BRCA1 Risk Genes, erbB-2 Menopause Odds Ratio Genetic Predisposition to Disease Cell Proliferation Time Factors Sensitivity and Specificity Cell Movement Drug Resistance, Neoplasm Gene Amplification Breast Feeding Parity Germ-Line Mutation Genes, BRCA2 Mutation Signal Transduction Genotype Apoptosis Cell Division Polymorphism, Genetic DNA Methylation Down-Regulation Up-Regulation Phenotype Genes, Tumor Suppressor Gene Expression Promoter Regions, Genetic Transfection Polymorphism, Single Nucleotide Chi-Square Distribution Cell Growth Processes Diet Phosphorylation Alleles Probability RNA Interference Gene Silencing Cell Cycle Cell Survival Dose-Response Relationship, Drug Cell Adhesion Genes, p53 Body Mass Index Tumor Microenvironment Base Sequence

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Age Distribution Quality of Life

Humanities1

Quality of Life

Information Science6

Incidence SEER Program Survival Rate Registries Questionnaires Base Sequence

Named Groups5

Survivors European Continental Ancestry Group African Americans Hispanic Americans Ethnic Groups

Health Care47

Risk Factors Case-Control Studies Survival Analysis Incidence Disease-Free Survival Follow-Up Studies Risk Assessment Risk Cohort Studies Multivariate Analysis SEER Program Proportional Hazards Models Age Factors Retrospective Studies Survival Rate Prospective Studies Odds Ratio Registries Mass Screening Treatment Outcome Predictive Value of Tests Kaplan-Meier Estimate Logistic Models Sensitivity and Specificity Reproducibility of Results Parity Confidence Intervals Confounding Factors (Epidemiology)Questionnaires Reproductive History Women's Health Age Distribution Chi-Square Distribution Age of Onset Family Health Randomized Controlled Trials as Topic Pilot Projects Models, Statistical Probability Cluster Analysis ROC Curve Regression Analysis Patient Selection Ethnic Groups Clinical Trials as Topic Analysis of Variance Body Mass Index

Geographicals7

United States California New Hampshire Sweden Wisconsin Norway Washington

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Breast Neoplasms Carcinoma, Ductal, Breast Breast Neoplasm Invasiveness Carcinoma, Intraductal, Noninfiltrating Receptors, Estrogen Receptors, Progesterone Receptor, erbB-2 Carcinoma, Lobular Mammography Prognosis Tumor Markers, Biological Carcinoma in Situ Tamoxifen Postmenopause Mastectomy Neoplasm Staging Cell Line, Tumor Immunohistochemistry Lymphatic Metastasis Breast Diseases Gene Expression Regulation, Neoplastic Mastectomy, Segmental Risk Factors Axilla Raloxifene Neoplasm Metastasis Antineoplastic Agents, Hormonal Premenopause Neoplasm Recurrence, Local Case-Control Studies Survival Analysis Incidence Breast Neoplasms, Male Carcinoma, Ductal Selective Estrogen Receptor Modulators Tissue Array Analysis Disease-Free Survival Carcinoma Early Detection of Cancer Follow-Up Studies Risk Assessment Neoplasm Proteins Genes, BRCA1 Risk Cohort Studies Multivariate Analysis Neoplasm Grading Genes, erbB-2 Chemotherapy, Adjuvant SEER Program Proportional Hazards Models Ki-67 Antigen Age Factors Retrospective Studies Survival Rate Menopause Prospective Studies Odds Ratio Antineoplastic Agents Registries Estrogen Replacement Therapy Disease Progression Estrogen Receptor Modulators Estrogen Receptor alpha Gene Expression Profiling Genetic Predisposition to Disease Estrogens Neoplasms, Ductal, Lobular, and Medullary Neoplasms, Hormone-Dependent United States Lymph Nodes Mass Screening Treatment Outcome Keratin-6 Predictive Value of Tests Sentinel Lymph Node Biopsy Cell Proliferation Tumor Cells, Cultured BRCA2 Protein Fibrocystic Breast Disease Hormone Replacement Therapy Kaplan-Meier Estimate Time Factors Ultrasonography, Mammary Mammary Glands, Human Mice, Nude BRCA1 Protein RNA, Messenger California Reverse Transcriptase Polymerase Chain Reaction Antineoplastic Combined Chemotherapy Protocols Radiotherapy, Adjuvant Keratin-5 Logistic Models Aromatase Inhibitors In Situ Hybridization, Fluorescence Sensitivity and Specificity DNA, Neoplasm Lymph Node Excision

No FAQ available that match "patients with invasive breast cancer"